Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01570842|
Recruitment Status : Completed
First Posted : April 4, 2012
Last Update Posted : March 31, 2014
|Condition or disease||Intervention/treatment|
|Gastroesophageal Reflux Disease (GERD)||Other: Anthropometric measurements Procedure: Tissue samples|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||The Role of Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury|
|Study Start Date :||October 2011|
|Primary Completion Date :||November 2012|
|Study Completion Date :||December 2012|
Anthropometric Measurements; Tissue Samples
All participants will have their waist circumference and waist to hip ratio taken as a measurement of central obesity. Participants undergoing clinically indicated upper endoscopy and who consent to providing tissue samples will have 8 tissue samples taken for future research purposes.
Other: Anthropometric measurements
All participants will have their waist circumference and waist to hip ratio taken as a measurement of central obesity.Procedure: Tissue samples
Participants undergoing clinically indicated upper endoscopy and who consent to providing tissue samples will have 8 tissue samples taken for future research purposes.
- Correlate Anthropometry with number of acid reflux episodes [ Time Frame: 1 year ]To correlate measures of central obesity waist/hip ratio (WHR) and waist circumference (WC) with number of reflux episodes (acidic and non acidic), and other measures of acid/non acid reflux. Stratify by use of proton pump inhibitors (PPIs).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01570842
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Prasad G Iyer, MD||Mayo Clinic|